Quent Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.72K Sell
135
-1
-0.7% -$70 ﹤0.01% 1185
2025
Q4
$9.15K Sell
136
-12
-8% -$807 ﹤0.01% 1169
2025
Q3
$10.9K Buy
+148
New +$9.83K ﹤0.01% 994
2025
Q2
Sell
-105
Closed -$6.7K 698
2025
Q1
$6.7K Hold
105
﹤0.01% 967
2024
Q4
$5.02K Hold
105
﹤0.01% 1036
2024
Q3
$6.01K Hold
105
﹤0.01% 1072
2024
Q2
$5.5K Hold
105
﹤0.01% 1068
2024
Q1
$4.27K Hold
105
﹤0.01% 1139
2023
Q4
$3.88K Hold
105
﹤0.01% 1111
2023
Q3
$4.01K Buy
105
+26
+33% +$1.06K ﹤0.01% 1093
2023
Q2
$2.85K Buy
+79
New +$2.69K ﹤0.01% 1144

Other funds holding HALO

Quent Capital's HALO Position: Q1 2026 in Review

Quent Capital reduced its Halozyme (HALO) stake by 0.74% in Q1 2026, selling an estimated $70 and leaving 135 shares worth $8.72K. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

Quent Capital first reported a position in HALO in Q2 2023 and has held it in 11 quarters since. The position peaked at $10.9K in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Quent Capital held 135 shares of Halozyme worth $8.72K as of Q1 2026.
  • Quent Capital sold 1 Halozyme share in Q1 2026, an estimated $70.
  • Halozyme made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1185 holding.
  • Quent Capital first reported a position in Halozyme in Q2 2023 and has held it in 11 quarters since.
  • Quent Capital's Halozyme position peaked at $10.9K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.